Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29668446 | 0.82 | PABPC1 (0.35) | PABPC1CTDSP1GAA | |
| SCHEMBL712042 | 0.74 | — | — | |
| SCHEMBL6388243 | 0.72 | PABPC1 (0.39) | PABPC1CTDSP1GAA | |
| SCHEMBL8634207 | 0.72 | PABPC1 (0.35) | PABPC1CTDSP1GAA | |
| SCHEMBL17470028 | 0.72 | PABPC1 (0.35) | PABPC1CTDSP1GAA | |
| SCHEMBL712028 | 0.71 | PABPC1 (0.36) | PABPC1CTDSP1GAA | |
| SCHEMBL6389818 | 0.69 | PABPC1 (0.36) | PABPC1CTDSP1GAA | |
| SCHEMBL8382509 | 0.69 | GAA (0.34) | PABPC1CTDSP1GAA | |
| SCHEMBL714295 | 0.68 | PABPC1 (0.33) | PABPC1CTDSP1GAA | |
| SCHEMBL5328127 | 0.67 | GAA (0.30) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150098903-A1 | Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders | THE GENERAL HOSPITAL CORPORATION | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150098903-A1 | Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders | APP, PSEN1, PSEN2 | PABPC1 3004/4885CTDSP1 4263/4885GAA 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.